Senior Leadership

高层领导

基本信息

批准号：
8340230
负责人：
KEVIN J. CULLEN
金额：
$ 12.57万
依托单位：
UNIVERSITY OF MARYLAND BALTIMORE
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
起止时间：
2011-08-24 至 2016-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8340230
关键词：
Administrator Africa Alcohol abuse Alcoholism American Cancer Society Antineoplastic Agents Area Baltimore Basic Science Biometry Biopolymers Budgets Cancer Biology Cancer Center Cancer Center Support Grant Capital Clinic Clinical Clinical Research Clinical Services Comprehensive Cancer Center Country County DNA Repair Data Development Development Plans Developmental Therapeutics Program Discipline District of Columbia Drug effect disorder Drug resistance Equipment Faculty Genomics Government Grant Growth Head and Neck Cancer Hospitals Human Virology Institutes Institutional Review Boards Intellectual Property Laboratories Leadership Malignant Neoplasms Maryland Mentors Monitor Patient Care Pharmacy facility Play Policies Population Sciences Positioning Attribute Procedures Process Radiation Oncology Radiation Therapy Oncology Group Recruitment Activity Reporting Research Research Activity Research Personnel Role Safety Scientist Services Strategic Planning System Technology Transfer Texas United States National Institutes of Health Universities Viral Epidemiology authority cancer epidemiology design drug development experience interest meetings member multidisciplinary news operation programs ranpirnase research and development

项目摘要

Dr. Kevin Cullen was appointed director of UMGCC in 2004 after a national search. Dr. Cullen has an outstanding reputation as a clinician scientist, with focused interest in head and neck cancer biology and the mechanism of drug action and drug resistance. He had previously served as the acting director of the Lombardi Comprehensive Cancer Center at Georgetown University in Washington, DC. Dr. Cullen is an active clinician and researcher and it is that combined expertise which has helped him successfully integrate the cancer clinical and research activities on the UMB campus and across the University System of Maryland. Dr. Cullen's tenure at UMGCC has seen remarkable growth in both clinical and research activities through focused planning and recruitment. Under Dr. Cullen's leadership, UMGCC obtained its first P30 CCSG in August 2008. In 2010, the U.S. News & World Report "Best Hospitals" rankings listed UMGCC at #21 of more than 900 cancer programs in the country, and in this ranking, UMGCC was #18 of all NCI designated centers. In 2009, Dr. Cullen was appointed to the national board ofthe American Cancer Society. An outstanding leadership team representing multiple disciplines assists Dr. Cullen in all aspects of strategic planning, recruitment, organization and operation. Dr. Edward Sausville, associate director for Clinical Research, was recruited in 2004. Dr. Sausville was previously director of Developmental Therapeutics at NCI and has an outstanding national reputation in cancer drug development. Since his arrival at UMGCC, Dr. Sausville has completely reorganized the clinical research operations and formed critical strategic alliances with other cancer centers across the county. Dr. Alan Tomkinson, associate director for Basic Science, was recruited to UMGCC in 2003. He previously held a similar position at the Cancer Center, University of Texas-San Antonio. In addition to outstanding expertise as a researcher in the area of DNA damage and repair. Dr. Tomkinson's previous experience has been invaluable to the reorganized research programs at UMGCC and the planned strategic recruitments. He has also developed and implemented a mentoring process for junior faculty. Mr. Stephen Long, associate director for Administration, was recruited to UMGCC in 2006, after a 28-year tenure as an administrator at the National Institute for Alcoholism and Alcohol Abuse (NIAAA), NIH. In his last 8 years there, he was executive officer of that institute. Mr. Long has overall administrative authority for the basic and clinical research operations of UMGCC and the development of the overall budget. He also has administrative responsibility for philanthropy and government relations. Dr. Mohan Suntharalingam, associate director for Clinical Services, was appointed in 2005. He is vice chair of the Department of Radiation Oncology and is PI for the University of Maryland's RTOG grant. Dr. Suntharalingam has administrative oversight of UMGCC's multidisciplinary clinical programs and has been instrumental in designing and implementing multidisciplinary clinics to facilitate patient care and clinical research. Dr. Nicholas Ambulos, director of Shared Services, has long been the director of the Biopolymer Shared Service (now the Genomics Shared Service) at UMSOM. In 2004, Dr. Cullen recruited him to be director of Shared Services at UMGCC. Dr. Ambulos has played a critical role in planning the development of shared services, standardizing operations, and evaluating the long-term service needs of UMGCC investigators. Dr. William Blattner was appointed associate director for Population Science in 2010. Dr. Blattner is also associate director of the Institute of Human Virology (IHV) and Chief of the newly formed Division of Cancer Epidemiology. Dr. Blattner directs clinical and research efforts of the IHV in Baltimore and West Africa. Dr. Blattner previously served as Chief ofthe Viral Epidemiology Branch at NCI.

凯文·库伦（Kevin Cullen）博士在全国搜索后于2004年被任命为UMGCC董事。 Cullen博士是临床医生的杰出声誉，对头颈癌生物学和药物作用和耐药性的机制的兴趣集中。他以前曾担任华盛顿特区乔治敦大学伦巴第综合癌症中心的代理总监。库伦博士是活跃的临床医生和研究人员，正是这种联合专业知识帮助他成功地将UMB校园和整个马里兰州大学系统的癌症临床和研究活动整合在一起。 Cullen博士在UMGCC的任期通过重点计划和招聘在临床和研究活动中都显着增长。在Cullen博士的领导下，UMGCC于2008年8月获得了首个P30 CCSG。2010年，美国新闻与世界报告“最佳医院”排名将UMGCC列为美国900多个癌症计划中的第21名，在该排名中， UMGCC在所有NCI指定中心中排名第18。 2009年，库伦博士被任命为美国癌症协会国家委员会。代表多个学科的杰出领导团队有助于库伦博士在战略规划，招聘，组织和运营的各个方面。临床研究副总监爱德华·索斯维尔（Edward Sausville）博士于2004年招募。萨斯维尔博士此前曾担任NCI发育疗法主任，并在癌症药物开发方面享有很高的国家声誉。自从他到达UMGCC以来，Sausville博士已经完全重组了临床研究运营并与全县其他癌症中心建立了关键的战略联盟。基础科学副总监Alan Tomkinson博士于2003年招募到UMGCC。除了在DNA损伤和维修领域担任研究人员的出色专业知识。 Tomkinson博士以前的经验对于UMGCC的重组研究计划以及计划中的战略招聘非常宝贵。他还为初级教师开发并实施了指导过程。行政管理副主任斯蒂芬·朗（Stephen Long）先生在美国国立局（NIH）国家酒精中毒与酒精滥用研究所（NIAAA）任职28年后，于2006年被招募到UMGCC。在过去的8年中，他曾担任该研究所的执行官。朗先生拥有UMGCC的基本和临床研究运作的总体行政权限以及整体预算的发展。他也有对慈善事业和政府关系的行政责任。临床服务副主任Mohan Suntharalingam博士于2005年任命。他是放射线肿瘤学系的副主席，是马里兰大学RTOG Grant的PI。 Suntharalingam博士对UMGCC的多学科临床计划进行了行政监督，并有助于设计和实施多学科诊所，以促进患者护理和临床研究。共享服务总监Nicholas Ambulos博士长期以来一直是UMSOM生物聚合物共享服务（现为基因组共享服务）的主任。 2004年，Cullen博士招募他担任UMGCC共享服务主任。 Ambulos博士在计划共享服务，标准化操作以及评估UMGCC调查人员的长期服务需求方面发挥了关键作用。威廉·布拉特纳（William Blattner）博士于2010年被任命为人口科学副主任。布拉特纳（Blattner）博士还是人类病毒学研究所（IHV）的副主任，也是新成立的癌症流行病学部负责人。 Blattner博士指导了巴尔的摩和西非IHV的临床和研究工作。 Blattner博士此前曾担任NCI病毒流行病学分公司的负责人。